Heparinless cardiopulmonary bypass with active-site blocked factor IXa: A preliminary study on the dog
Open Access
- 31 May 1998
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 115 (5) , 1179-1188
- https://doi.org/10.1016/s0022-5223(98)70419-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass: A double-blind placebo-controlled studyThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: Successful for aortic valve replacement in manThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Myocardial Ischemia After Cardiopulmonary BypassJournal of Cardiac Surgery, 1995
- Iloprost and echistatin protect platelets during simulated extracorporeal circulationThe Annals of Thoracic Surgery, 1995
- Evaluation of CGP 39393 as the anticoagulant in cardiopulmonary bypass operation in a dog modelThe Annals of Thoracic Surgery, 1994
- Blood-Surface Interactions During Cardiopulmonary BypassJournal of Cardiac Surgery, 1993
- Ancrod (Arvin®) as an Alternative to Heparin Anticoagulation for Cardiopulmonary BypassAnesthesiology, 1989
- Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.Journal of Clinical Investigation, 1981
- Epsilon-Aminocaproic Acid for Bleeding After Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1971